09/16/2024 | Press release | Distributed by Public on 09/16/2024 07:42
Mastercard announced that its Chief Financial Officer, Sachin Mehra, has informed the Mastercard Board of Directors and his colleagues that he will be undergoing treatment for non-Hodgkin lymphoma. It was detected very early, with scans and biopsies indicating it is highly localized and curable. With the recommended treatment, Sachin's long-term prognosis is excellent. He will remain actively involved in daily operations, working remotely for the coming months.